Головна » Файли » 2013 » 1 (115) |
15.05.2014, 10:52 | |
Резюме УДК 616.441 – 006.5:616.34 Bukovinian State Medical University 58002, Chernivtsi, Theatre Square. 2 Буковинский государственный медицинский университет 58002, г. Черновцы, Театральна пл., 2 ipolyanskaya@ukr.net Increased interest of the problems of thyroid disease in recent years caused by its increasing prevalence among the population in Ukraine. In the structure of endocrine diseases principal place belongs to toxic goiter forms (TGF) (47.3%). Thyrotoxicosis is a syndrome of higher concentrations of thyroid hormones, occurs in 3% of women and 0.3% of men. Thyrotoxicosis has a pathological effect on all organs and systems of the body, especially the activity of the digestive system. Enteric disorders occur in 60% of patients with TGF. The problem of comorbidity - course of irritable bowel syndrome (IBS) and thyrotoxicosis poorly studied. The purpose of research was to analyze long-term results of treatment of patients with toxic goiter forms and irritable bowel syndrome by the use meteospasmyl and carvedilol. Materials and methods.Study involved 106 patients with TGF. The average age of patients was 32,5±1,6 years. All patients were examined, which included the collection of complaints, anamnesis, objective examination, laboratory and instrumental investigations. The diagnosis of thyrotoxicosis exhibited due to clinical, laboratory (level of TSH, free T3 and T4) and instrumental data. The diagnosis of IBS exhibited due to the Rome III criteria (2006). The level of serotonin examined by ELISA using reagents "DRG" (Germany). All the patients were divided into 3 groups. The first group included 35 patients with TGF combined with IBS- diarrhea type, second group - 34 patients with thyrotoxicosis and IBS with a predominance of constipation. 3rd group consisted of 37 patients with TGF without disorders of the digestive system. Control group involved 20 healthy individuals. In addition to basic therapy patients of 1st and 2nd group received meteospasmyl in a dose 1 capsule 3 times a day and α, β-blocker carvedilol in a dose 12.5 mg 1 time per day. The study was conducted in dynamics: before treatment and after 1 year. Results. In assessing the levels of thyroid hormones in a year after treatment revealed that in all groups the concentrations of TSH, free T3 and T4 were normal, that shows the effectiveness of the proposed treatment to achieve thyroid homeostasis. In analyzing the dynamics of the concentration of serotonin in plasma a year after treatment revealed that the use of combined treatment resulted in its stabilization. Thus, in 1st and 2nd group the concentration of serotonin was significantly lower compared to that before treatment. It shows recovery of neuro-humoral balance, which has a positive effect on bowel function. In assessing HRV in remote period of treatment, it was found that heart rate one year after treatment was significantly lower than before treatment in all groups and reached physiological parameters. The value of SDNN and SDANN in patients of 2nd group increased after a year of treatment. Index rMSSD decreased in group 1 after a year of treatment. Parameters of pNN50 in patients of 1st group were significantly lower than before treatment, in patients of the 2nd and 3rd group - significantly higher. The analysis of HRV indicates the restoration of balance between sympathetic and parasympathetic nervous system by the use of meteospasmyl and carvedilol. In estimating the parameters of the questionnaire MOS SF-36, we found differences in groups of patients depending on the type of intestinal dysfunction. The highest parameters observed in patients of group 3, although dynamics of pre-and post-treatment was less pronounced. Lower quality of life characteristic was found in patients of group 2. Conclusion. The use of meteospasmyl and carvedilol after a year contributed to normalization of thyroid hormones level, serotonin concentration, restoration of autonomic nervous balance and improved the quality of life of patients with toxic goiter forms and irritable bowel syndrome. Література
| |
Переглядів: 1293 | Завантажень: 0 | |
Всього коментарів: 0 | |